《新股消息》據報阿裏參投電商「匯通達」研押後本港IPO計劃至明年
據《彭博通訊社》引述消息稱,阿裏巴巴(09988.HK)有份投資的中國農村電商匯通達正考慮將本港上市計劃押後至明年。
匯通達早於今年6月向港交所(00388.HK)遞上市申請,據悉擬集資最多10億美元。消息稱,內地收緊監管及導致市場波動,促使匯通達押後上市事宜。知情人士稱,討論仍在繼續,仍有機會選擇在今年上市。
據初步招股文件顯示,截至2020年12月31日,匯通達業務覆蓋中國21個省及直轄市、超19,000個鄉鎮,連接超過140,000家會員零售門店、10,000家供貨商及18,000家渠道合作客戶,惠及超過3億農民消費者。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.